Michael Senseney

Michael Senseney joined NJ Bio in December 2018 as a Senior Associate Scientist and is currently Director of Bioconjugation. Michael has expertise in bioconjugations, expression, and purification of antigens and antibodies for oncology ADC research. He is well versed in the characterization of purified antibodies and fusion proteins techniques such as plate-based assays, Westerns, and capillary electrophoresis, and assay development for pre-clinical materials including methods to fragment antibodies and labeling of purified materials for internalization and binding assays. Prior to NJ Bio, Michael was at Agensys, Inc. where he primarily worked in the bioconjugation area, and at Athena Enzyme Systems, where he worked on globally distributed research products, expressed proteins from E. coli, and purified them using liquid chromatography and TFF ultra-filtration for customers and participated in an SBIR Grant. Michael has an Associate Degree in Biotechnology from the Community College of Baltimore County and a B.S. in Molecular Biology, Biochemistry, and Bioinformatics from Towson University.